Discover and read the best of Twitter Threads about #Lineages
Most recents (16)
Tracking #SARSCoV2 #Lineages - Globally
Top lineages -#20DayTrends (#G20):
XBB.1.5 (16.5%)⬇️
XBB.1.16 (10.5%)⬆️
XBB.1.9.1 (7.3%)
FL.4 (4%)
EG.1 (3.6%)
XBB.1.16.1 (3.4%)
XBB.1.9.2 (3.2%)
XBB.2.3.2 (2.6%)
FL.2 (2.5%)
FU.1 (2.1%)
public.tableau.com/app/profile/ra…
Updated 6/4/23
Top lineages -#20DayTrends (#G20):
XBB.1.5 (16.5%)⬇️
XBB.1.16 (10.5%)⬆️
XBB.1.9.1 (7.3%)
FL.4 (4%)
EG.1 (3.6%)
XBB.1.16.1 (3.4%)
XBB.1.9.2 (3.2%)
XBB.2.3.2 (2.6%)
FL.2 (2.5%)
FU.1 (2.1%)
public.tableau.com/app/profile/ra…
Updated 6/4/23
Granular details #Global #20DayTrends
This analysis includes all designated #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 05/15/2023 (6,574 sequences)
This analysis includes all designated #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 05/15/2023 (6,574 sequences)
In Silico Immune escape and ACE2 receptor binding scores (relative to BA.2)*
Data is intended to prioritize select lineages to generate rapid laboratory experiments to gauge immune escape and ACE2 binding affinity.
[Credits in the legend] *Only Spike RBD mutations considered
Data is intended to prioritize select lineages to generate rapid laboratory experiments to gauge immune escape and ACE2 binding affinity.
[Credits in the legend] *Only Spike RBD mutations considered
Tracking #SARSCoV2 #Lineages - Globally
Top lineages -#20DayTrends (#G20):
XBB.1.5 (36.6%)⬇️
XBB.1.9.1 (11.5%)⬆️
EG.1 (4.7%)⬆️
XBB.1.16 (4.4%)⬆️
XBB.1.9.2 (3.1%)
XBB.2.3 (1.8%)
XBB.1.5.13 (1.6%)
XBB.1.16.1 (1.5%)
public.tableau.com/app/profile/ra…
Updated 04/29/23
Top lineages -#20DayTrends (#G20):
XBB.1.5 (36.6%)⬇️
XBB.1.9.1 (11.5%)⬆️
EG.1 (4.7%)⬆️
XBB.1.16 (4.4%)⬆️
XBB.1.9.2 (3.1%)
XBB.2.3 (1.8%)
XBB.1.5.13 (1.6%)
XBB.1.16.1 (1.5%)
public.tableau.com/app/profile/ra…
Updated 04/29/23
Granular details #Global #20DayTrends
This analysis includes all designated #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 04/09/2023 (14,137 sequences)
This analysis includes all designated #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 04/09/2023 (14,137 sequences)
#USA, #Austria, #France & #Canada have submitted a lion's share of sequences with sample collection dates on or after 04/09/2023 ...followed by #UnitedKingdom, #Australia, #Germany, #Sweden, #SouthKorea, #Singapore, #China, #Spain
#VariantDashboard #India - #30DayTrends
Top lineages:
XBB.1.16 (62.6%)
XBB.1.16.1 (9.3%)
XBB.2.3 (6.7%)
XBB.1.16 + NS3_V13L (4.7%)
XBB.2.3.2 (4%)
XBB.1.5 (3.8%)
XBB.1 (1.9%)
XBB.2.3.4 (1.2%)
XBB.2.3.3 (0.9%)
XBB.2.3.5 (0.7%)
Tracker:public.tableau.com/app/profile/ra…
04/18/23
Top lineages:
XBB.1.16 (62.6%)
XBB.1.16.1 (9.3%)
XBB.2.3 (6.7%)
XBB.1.16 + NS3_V13L (4.7%)
XBB.2.3.2 (4%)
XBB.1.5 (3.8%)
XBB.1 (1.9%)
XBB.2.3.4 (1.2%)
XBB.2.3.3 (0.9%)
XBB.2.3.5 (0.7%)
Tracker:public.tableau.com/app/profile/ra…
04/18/23
Granular details - #VariantDashboard #India - #30DayTrends
XBB.1.16* (76.7%) is still the dominant variant group in #India, followed by XBB.2.3* (13.5%) Note: Data limited to few States that are sequencing and rapidly submitting data
XBB.1.16* (76.7%) is still the dominant variant group in #India, followed by XBB.2.3* (13.5%) Note: Data limited to few States that are sequencing and rapidly submitting data
#VariantDashboard #30DayTrends - #Delhi
XBB.1.16 (50.8%)
XBB.1.16+NS3_V13L (11.7%) 👀
XBB.1.16.1 (10.1%)
XBB.2.3 (6.8%)
XBB.2.3.2 (5.6%)
XBB.1.5 (4.5%)
XBB.1.9.1 (3.1%)
XBB.1.16 (50.8%)
XBB.1.16+NS3_V13L (11.7%) 👀
XBB.1.16.1 (10.1%)
XBB.2.3 (6.8%)
XBB.2.3.2 (5.6%)
XBB.1.5 (4.5%)
XBB.1.9.1 (3.1%)
Tracking #SARSCoV2 #Lineages - Globally
Top lineages -#20DayTrends (#G20):
XBB.1.5 (46.4%)⬇️
XBB.1.9.1 (10.1%)⬆️
XBB.1.16 (4.9%)⬆️
EG.1 (3.7%)⬆️
CH.1.1 (2.3%)⬇️
XBB.1.9.2 (2.3%)
--
XBB.2.3 (1.3%)⬆️
Tracker: public.tableau.com/app/profile/ra…
Updated 04/15/23
Top lineages -#20DayTrends (#G20):
XBB.1.5 (46.4%)⬇️
XBB.1.9.1 (10.1%)⬆️
XBB.1.16 (4.9%)⬆️
EG.1 (3.7%)⬆️
CH.1.1 (2.3%)⬇️
XBB.1.9.2 (2.3%)
--
XBB.2.3 (1.3%)⬆️
Tracker: public.tableau.com/app/profile/ra…
Updated 04/15/23
Granular details #Global #20DayTrends
This analysis includes all designated #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 03/26/2023 (15,505 sequences)
This analysis includes all designated #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 03/26/2023 (15,505 sequences)
#USA, #Austria, #UnitedKingdom & #Canada have submitted a lion's share of sequences with sample collection dates on or after 03/26/2023 ...followed by #Germany, #France, #India, #Italy, #Australia, #Sweden, #Denmark, #Singapore, #SouthKorea, #Spain, #Netherlands
#VariantDashboard #India - #30DayTrends
Top lineages:
XBB.1.16 (62%)
XBB.1.16.1 (10.1%)
XBB.2.3 (7.3%)
XBB.1.5 (5.7%)
XBB.2.3.2 (4%)👀
XBB.1 (1.8%)
XBB.1.9.1 (1.7%)
XBB.2.3.4 (1.5%)👀
XBB.2.3.3 (0.9%)
XBB.2.3.5 (0.9%)
Tracker: public.tableau.com/app/profile/ra…
04/13/23
Top lineages:
XBB.1.16 (62%)
XBB.1.16.1 (10.1%)
XBB.2.3 (7.3%)
XBB.1.5 (5.7%)
XBB.2.3.2 (4%)👀
XBB.1 (1.8%)
XBB.1.9.1 (1.7%)
XBB.2.3.4 (1.5%)👀
XBB.2.3.3 (0.9%)
XBB.2.3.5 (0.9%)
Tracker: public.tableau.com/app/profile/ra…
04/13/23
Granular details - #VariantDashboard #India - #30DayTrends
XBB.1.16* (71.1%) is still the dominant variant group in #India, followed by XBB.2.3* (14.6%)
Note: Data limited to few States that are sequencing and rapidly submitting data
XBB.1.16* (71.1%) is still the dominant variant group in #India, followed by XBB.2.3* (14.6%)
Note: Data limited to few States that are sequencing and rapidly submitting data
Tracking #SARSCoV2 lineage XBB.1.16* (#Arcturus) over time in #India
XBB.1.16* sequence count: 1,807
Hotspots: #Gujarat, #Maharashtra, #Delhi, #Karnataka, #TamilNadu, #Haryana, #Goa
Note: Recent Epi-Weeks are incomplete public.tableau.com/app/profile/ra…
XBB.1.16* sequence count: 1,807
Hotspots: #Gujarat, #Maharashtra, #Delhi, #Karnataka, #TamilNadu, #Haryana, #Goa
Note: Recent Epi-Weeks are incomplete public.tableau.com/app/profile/ra…
#VariantDashboard #India - #30DayTrends
Top circulating lineages:
XBB.1.16 (61%)
XBB.2.3* (15%) 👀
XBB.1.16.1 (10%)👀
XBB.1.5 (6%)
XBB.1 (1.8%)
XBB.1.9.1 (1.8%)
*includes several newly designated XBB.2.3.x
Tracker: public.tableau.com/app/profile/ra…
Updated: 04/12/2023
Top circulating lineages:
XBB.1.16 (61%)
XBB.2.3* (15%) 👀
XBB.1.16.1 (10%)👀
XBB.1.5 (6%)
XBB.1 (1.8%)
XBB.1.9.1 (1.8%)
*includes several newly designated XBB.2.3.x
Tracker: public.tableau.com/app/profile/ra…
Updated: 04/12/2023
Granular details - #VariantDashboard #India - #30DayTrends
XBB.1.16* (71%) is still the dominant variant group in #India
Note: Data limited to few States that are sequencing and rapidly submitting data
XBB.1.16* (71%) is still the dominant variant group in #India
Note: Data limited to few States that are sequencing and rapidly submitting data
Tracking #SARSCoV2 lineage XBB.1.16* (#Arcturus) over time in #India
XBB.1.16* sequence count: 1,795
XBB.1.6.1 sequence count: 299
Hotspots: #Gujarat, #Maharashtra, #Delhi👀, #Karnataka, #TamilNadu, #Haryana
Note: Recent Epi-Weeks are incomplete
public.tableau.com/app/profile/ra…
XBB.1.16* sequence count: 1,795
XBB.1.6.1 sequence count: 299
Hotspots: #Gujarat, #Maharashtra, #Delhi👀, #Karnataka, #TamilNadu, #Haryana
Note: Recent Epi-Weeks are incomplete
public.tableau.com/app/profile/ra…
Tracking #SARSCoV2 #Lineages - Globally
Top lineages -#20DayTrends (#G20):
XBB.1.5 (48.1%)⬆️
XBB.1.9.1 (6.5%)⬆️
CH.1.1 (3.6%)
BQ.1.1 (2.6%)
EG.1 (2.4%)⬆️
CH.1.1.1 (2.1%)
..
XBB.1.16 (1.6%)👀
** includes Spike only seqs
Tracker: public.tableau.com/app/profile/ra…
Updt 03/26/23
Top lineages -#20DayTrends (#G20):
XBB.1.5 (48.1%)⬆️
XBB.1.9.1 (6.5%)⬆️
CH.1.1 (3.6%)
BQ.1.1 (2.6%)
EG.1 (2.4%)⬆️
CH.1.1.1 (2.1%)
..
XBB.1.16 (1.6%)👀
** includes Spike only seqs
Tracker: public.tableau.com/app/profile/ra…
Updt 03/26/23
Granular details #Global #20DayTrends
This analysis includes all designated #SARSCoV2 sequences submitted to GISAID with sample collection dates on or after 03/06/2023 (25,590 sequences)
Contains many spike sequences from Austria
This analysis includes all designated #SARSCoV2 sequences submitted to GISAID with sample collection dates on or after 03/06/2023 (25,590 sequences)
Contains many spike sequences from Austria
#USA, #UnitedKingdom & #Austria have submitted a lion's share of sequences with sample collection dates on or after 03/06/2023 ...followed by #Canada, #Germany, #Denmark, #Australia, #Italy, #France, #Nertherlands, #India, #Poland
Tracking #SARSCoV2 #Lineages - Globally
Top lineages -#20DayTrends (#G20):
BQ.1.1 (18.9%)
XBB.1.5 (18.7%)👀^
CH.1.1 (5.3%)👀
BQ.1 (3.7%)
XBB.1 (2.7%)
BA.5.2.48 (2.3%)
XBF (1.7%)
^more sequences from USA in this period
Tracker: public.tableau.com/app/profile/ra…
Updated 02/02/2023
Top lineages -#20DayTrends (#G20):
BQ.1.1 (18.9%)
XBB.1.5 (18.7%)👀^
CH.1.1 (5.3%)👀
BQ.1 (3.7%)
XBB.1 (2.7%)
BA.5.2.48 (2.3%)
XBF (1.7%)
^more sequences from USA in this period
Tracker: public.tableau.com/app/profile/ra…
Updated 02/02/2023
Granular details #Global #20DayTrends
This analysis includes all designated #SARSCoV2 sequences submitted to GISAID with sample collection dates on or after 01/12/2023
This analysis includes all designated #SARSCoV2 sequences submitted to GISAID with sample collection dates on or after 01/12/2023
USA has submitted a lion's share of sequences with sample collection dates on or after 01/12/2023 ...followed by #Canada, #UnitedKingdom, #Austria, #Japan, #Denmark, #Germany, #France, #China, #Australia, #Italy
Tracking #SARSCoV2 #Convergent #Lineages ( aka #VariantSoup) over time - Globally | #30DayTrends
BQ.1.1 is currently leading the charts!
Followed by BQ.1, BA.2.75.2*, XBB.1 and BA.2.3.20
Tracker: public.tableau.com/app/profile/ra…
Updated 10/19/2022 7:30 pm
BQ.1.1 is currently leading the charts!
Followed by BQ.1, BA.2.75.2*, XBB.1 and BA.2.3.20
Tracker: public.tableau.com/app/profile/ra…
Updated 10/19/2022 7:30 pm
Note: Tracker includes Preselected from Austria and Airport Screening from Japan and USA
Top Lineages with Convergent Mutations-
BQ.1.1
BQ.1
BA.2.75.2
XBB.1
BA.2.3.20
BN.1
BM.1.1.3
BA.2.75.5
BL.1
BQ.1.2
...
3/n
BQ.1.1
BQ.1
BA.2.75.2
XBB.1
BA.2.3.20
BN.1
BM.1.1.3
BA.2.75.5
BL.1
BQ.1.2
...
3/n
Tracking #SARSCoV2 #Convergent #Lineages ( aka #VariantSoup) over time - Globally | #30DayTrends
BQ.1.1(#Cerberus) is currently leading the charts!
BQ.1 (#Typhon) & BA.2.75.2* (#Chiron) are not far behind!
Tracker: public.tableau.com/app/profile/ra…
Updated 10/13/2022
BQ.1.1(#Cerberus) is currently leading the charts!
BQ.1 (#Typhon) & BA.2.75.2* (#Chiron) are not far behind!
Tracker: public.tableau.com/app/profile/ra…
Updated 10/13/2022
Note: Tracker includes Preselected (PS) or Airport Screening (AS) from the following countries
BA.2.3.20*:
108 Austria (PS)
11 Japan (AS)
XBB*
17 Austria (PS)
10 Japan (AS)
BQ*
6 Austria (PS)
7 Japan (AS)
7 USA (AS)
BA.2.75*
269 Austria (PS)
21 Japan (AS)
10 USA (AS)
2/n
BA.2.3.20*:
108 Austria (PS)
11 Japan (AS)
XBB*
17 Austria (PS)
10 Japan (AS)
BQ*
6 Austria (PS)
7 Japan (AS)
7 USA (AS)
BA.2.75*
269 Austria (PS)
21 Japan (AS)
10 USA (AS)
2/n
Granular details - #VariantSoup with Convergent Mutations #30DayTrends
Top Lineages with Convergent Mutations-
BQ.1.1*
BQ.1*
BA.2.75.2*
BM.1.1*
XBB.1*
BN.1*
BA.2.3.20*
BA.2.75.5*
BL.1*
BA.2.75.1*
BY.1*
3/n
Top Lineages with Convergent Mutations-
BQ.1.1*
BQ.1*
BA.2.75.2*
BM.1.1*
XBB.1*
BN.1*
BA.2.3.20*
BA.2.75.5*
BL.1*
BA.2.75.1*
BY.1*
3/n
Tracking #SARSCoV2 #Convergent #Lineages ( aka #VariantSoup) over time - Globally | #30DayTrends
BQ.1 (#Typhon)/BQ.1.1(#Cerberus) are currently at the top & BA.2.75.2* (#Chiron) is not far behind!
Tracker: public.tableau.com/app/profile/ra…
Updated 10/7/2022
BQ.1 (#Typhon)/BQ.1.1(#Cerberus) are currently at the top & BA.2.75.2* (#Chiron) is not far behind!
Tracker: public.tableau.com/app/profile/ra…
Updated 10/7/2022
Granular details - #VariantSoup with Convergent Mutations #30DayTrends
BQ.1/BQ.1.1 and BA.2.75.2 are heading the charts!
2/n
BQ.1/BQ.1.1 and BA.2.75.2 are heading the charts!
2/n
Tracked #Convergent #lineages are predicted to be immune evasive and bind to host ACE2 receptor better than Omicron.BA2
XBB is most immune evasive
Most BA.2.75* binds better to ACE2 receptors
Closely watched lineages - XBB, BM.1.1.1, CA.1, BQ.1.1, BN.1
3/n
XBB is most immune evasive
Most BA.2.75* binds better to ACE2 receptors
Closely watched lineages - XBB, BM.1.1.1, CA.1, BQ.1.1, BN.1
3/n
Tracking #SARSCoV2 #Convergent #Lineages ( aka #VariantSoup) over time - Globally | #30DayTrends
BQ.1 (#Typhon)/BQ.1.1(#Cerberus) are currently at the top & BA.2.75.2* (#Chiron) is not far behind!
Tracker: public.tableau.com/app/profile/ra…
Updated 10/6/2022
BQ.1 (#Typhon)/BQ.1.1(#Cerberus) are currently at the top & BA.2.75.2* (#Chiron) is not far behind!
Tracker: public.tableau.com/app/profile/ra…
Updated 10/6/2022
Granular details - #VariantSoup with Convergent Mutations #30DayTrends
BQ.1/BQ.1.1 and BA.2.75.2 are heading the charts!
2/n
BQ.1/BQ.1.1 and BA.2.75.2 are heading the charts!
2/n
Tracked #Convergent #lineages are predicted to be immune evasive and bind to host ACE2 receptor better than Omicron.BA2
XBB is most immune evasive
Most BA.2.75* binds better to ACE2 receptors
Closely watched lineages - XBB, CA.1, BQ.1.1, BN.1, BR.3
3/n
XBB is most immune evasive
Most BA.2.75* binds better to ACE2 receptors
Closely watched lineages - XBB, CA.1, BQ.1.1, BN.1, BR.3
3/n
Tracking #SARSCoV2 #Convergent #Lineages** over time - Globally | 10/5/2022
BQ.1 (#Typhon)/BQ.1.1(#Cerberus) is currently at the top & BA.2.75.2* (#Chiron) is not far behind!
public.tableau.com/app/profile/ra…
** aka #VariantSoup #Pentagon #ConvergentQuintet and others in social media
BQ.1 (#Typhon)/BQ.1.1(#Cerberus) is currently at the top & BA.2.75.2* (#Chiron) is not far behind!
public.tableau.com/app/profile/ra…
** aka #VariantSoup #Pentagon #ConvergentQuintet and others in social media
Granular details - "Convergent Quintet"
BQ.1/BQ.1.1 and BA.2.75.2 are heading the charts!
2/n
BQ.1/BQ.1.1 and BA.2.75.2 are heading the charts!
2/n
Tracked #Convergent #lineages are predicted to be immune evasive and bind to host ACE2 receptor better than Omicron.BA2
XBB is most immune evasive
Most BA.2.75* binds better to ACE2 receptors
Closely watched lineages - XBB, CA.1, BQ.1.1, BN.1, BR.3
3/n
XBB is most immune evasive
Most BA.2.75* binds better to ACE2 receptors
Closely watched lineages - XBB, CA.1, BQ.1.1, BN.1, BR.3
3/n
#COVID19 #VariantDashboard - #UnitedStates
TOP lineages (15-DAY TRENDS):
24.63% BA.2.12.1, <- Spike:L452Q
17.54% BA.2,
14.93% BA.2.9,
12.00% BA.2.12,
11.38% BA.2.10,
9.55% BA.2.3, and
2.35% BA.1.1
Tracker (by State): tinyurl.com/mryj4uu7
#OmicronUpdates 05/01/22
TOP lineages (15-DAY TRENDS):
24.63% BA.2.12.1, <- Spike:L452Q
17.54% BA.2,
14.93% BA.2.9,
12.00% BA.2.12,
11.38% BA.2.10,
9.55% BA.2.3, and
2.35% BA.1.1
Tracker (by State): tinyurl.com/mryj4uu7
#OmicronUpdates 05/01/22
#OmicronVariantUpdates #UnitedStates 05/01/22
Top circulating #sublineages: BA.2.12.1, BA.2*, BA.2.9, BA.2.12, BA.2.10, BA.2.3, and BA.1.1
* includes recently designated BA.2.x.y
Top circulating #sublineages: BA.2.12.1, BA.2*, BA.2.9, BA.2.12, BA.2.10, BA.2.3, and BA.1.1
* includes recently designated BA.2.x.y
1. Officiellement, d'après l'#OMS, il n'existe toujours qu'un unique variant #delta B.1.617.2
Les >200 #lineages (lignages/souches) qui en dérivent ne sont même pas "under investigation".
Ex. : très intéressante vigilance en UK, isn't it?🤨
Les >200 #lineages (lignages/souches) qui en dérivent ne sont même pas "under investigation".
Ex. : très intéressante vigilance en UK, isn't it?🤨
2. Ainsi en UK on ne trouve plus guère que la souche AY.4, qui a essaimé un peu partout dans le monde.
Comme en #Lituanie où elle s'est déclinée en AY.4.5 mais qui n'est toujours *rien d'autre qu'un delta*.
Or même si comparaison n'est pas raison :
ourworldindata.org/explorers/coro…
Comme en #Lituanie où elle s'est déclinée en AY.4.5 mais qui n'est toujours *rien d'autre qu'un delta*.
Or même si comparaison n'est pas raison :
ourworldindata.org/explorers/coro…
3. Même si la vaccination est un peu inférieure en Lituanie (surtout chez les + jeunes), a-t-on vraiment l'impression d'avoir affaire au même variant ?
Et aucune mesure spécifique pour les voyageurs en provenance de Lituanie.
La fameuse frontière anti-Tchernobyl & anti AY.4.5🚧
Et aucune mesure spécifique pour les voyageurs en provenance de Lituanie.
La fameuse frontière anti-Tchernobyl & anti AY.4.5🚧
Daily Bookmarks to GAVNet 01/27/2021 greeneracresvaluenetwork.wordpress.com/2021/01/27/dai…
Biden wants to squeeze an extra shot of vaccine out of every Pfizer vial. It won’t be easy.
washingtonpost.com/business/2021/…
#vaccine #distribution #contract
washingtonpost.com/business/2021/…
#vaccine #distribution #contract
More garbage than water: Serbia promises clean-up of hydro reservoir
reuters.com/article/us-env…
#environment #contamination #CleanUp #sustainability
reuters.com/article/us-env…
#environment #contamination #CleanUp #sustainability
